These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12966127)

  • 1. Effect of awareness of a randomized controlled trial on use of experimental therapy.
    Clark WF; Garg AX; Blake PG; Rock GA; Heidenheim AP; Sackett DL
    JAMA; 2003 Sep; 290(10):1351-5. PubMed ID: 12966127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exchange in Canada. The Canadian Apheresis Study Group.
    Rock GA; Tricklebank GW; Kasaboski CA
    CMAJ; 1990 Mar; 142(6):557-62. PubMed ID: 2178759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic apheresis: history, clinical application, and lingering uncertainties.
    McLeod BC
    Transfusion; 2010 Jul; 50(7):1413-26. PubMed ID: 19951311
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.
    Rock GA; Shumak KH; Buskard NA; Blanchette VS; Kelton JG; Nair RC; Spasoff RA
    N Engl J Med; 1991 Aug; 325(6):393-7. PubMed ID: 2062330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The indication of steroid pulse therapy and apheresis therapy for multiple sclerosis].
    Ohji S; Nomura K
    Nihon Rinsho; 2008 Jun; 66(6):1127-32. PubMed ID: 18540358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic hemapheresis practitioners need to know about the treatment of thrombotic thrombocytopenic purpura.
    Golden PJ
    Transfus Apher Sci; 2003 Jun; 28(3):215-7. PubMed ID: 12725945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of randomized controlled trials using therapeutic apheresis.
    Shehata N; Kouroukis C; Kelton JG
    Transfus Med Rev; 2002 Jul; 16(3):200-29. PubMed ID: 12075559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.
    Peters NO; Laurain E; Cridlig J; Hulin C; Cao-Huu T; Frimat L
    Hemodial Int; 2011 Oct; 15(4):538-45. PubMed ID: 22111823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of autologous hemopoietic progenitor cell collection in tandem with hemodialysis in multiple myeloma with myeloma cast nephropathy.
    Weinstein R; Kershaw G; Bailey J; Greene M; Chhibber V; Vauthrin M; Nath R; Galvin Karr E
    J Clin Apher; 2014 Apr; 29(2):83-9. PubMed ID: 23959911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of virus-inactivated plasma in apheresis treatment of thrombotic thrombocytopenic purpura: preliminary data].
    Russi G; De Silvestro G; Savignano C;
    G Ital Nefrol; 2012; 29 Suppl 54():S49-53. PubMed ID: 22388830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trials in therapeutic apheresis.
    Winters JL
    J Clin Apher; 2013 Feb; 28(1):48-55. PubMed ID: 23371830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic plasma exchange: an update from the Canadian Apheresis Group.
    Clark WF; Rock GA; Buskard N; Shumak KH; LeBlond P; Anderson D; Sutton DM
    Ann Intern Med; 1999 Sep; 131(6):453-62. PubMed ID: 10498563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and appraisal of randomized controlled trials in myeloma.
    Djulbegovic B; Adams JR; Lyman GH; Lacevic M; Hozo I; Greenwich M; Bennett CL
    Ann Oncol; 2001 Nov; 12(11):1611-7. PubMed ID: 11822763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Canadian apheresis registry.
    Rock G; Clark B; Sutton D; ;
    Transfus Apher Sci; 2003 Oct; 29(2):167-77. PubMed ID: 12941357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic plasma exchange: a review of the literature].
    Andrulli S; Bigi MC; Granata A; Cossu M; Logias F
    G Ital Nefrol; 2012; 29 Suppl 54():S40-8. PubMed ID: 22388829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National survey of hemapheresis practice in Hungary 2001-2004.
    Belák M; Jákó J
    Ther Apher Dial; 2007 Feb; 11(1):22-9. PubMed ID: 17309571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic apheresis for renal disorders.
    Sanchez AP; Ward DM
    Semin Dial; 2012; 25(2):119-31. PubMed ID: 22428811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic apheresis in hematological and oncological diseases.
    Grima KM
    J Clin Apher; 2000; 15(1-2):28-52. PubMed ID: 10767050
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
    Borrego-Hinojosa J; Pérez-del Barrio MP; Biechy-Baldan Mdel M; Merino-García E; Sánchez-Perales MC; García-Cortés MJ; Ocaña-Pérez E; Gutiérrez-Rivas P; Liébana-Cañada A
    Nefrologia; 2013; 33(4):515-23. PubMed ID: 23897183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of data of patients with Thrombotic Microangiopathy in the WAA registry.
    Mörtzell M; Berlin G; Nilsson T; Axelsson CG; Efvergren M; Audzijoni J; Griskevicius A; Ptak J; Blaha M; Tomsova H; Liumbruno GM; Centoni P; Newman E; Eloot S; Dhondt A; Tomaz J; Witt V; Rock G; Stegmayr B
    Transfus Apher Sci; 2011 Oct; 45(2):125-31. PubMed ID: 21903476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.